Cabergoline versus levodopa monotherapy: a decision analysis.
Smala AM, Spottke EA, Machat O, Siebert U, Meyer D, Köhne-Volland R, Reuther M, DuChane J, Oertel WH, Berger KB, Dodel RC.
Smala AM, et al.
Mov Disord. 2003 Aug;18(8):898-905. doi: 10.1002/mds.10465.
Mov Disord. 2003.
PMID: 12889079